Global Facial Injectable Market By Product (Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Other Products) By Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Other Applications) End-use(MedSpa, Dermatology Clinics, Hospitals) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Nov 2023
- Report ID: 48313
- Number of Pages: 260
- Format:
- keyboard_arrow_up
Quick Navigation
Market Overview
The Global Facial Injectables Market size is expected to be worth around USD 40.4 Billion by 2033 from USD 14.1 Billion in 2023, growing at a CAGR of 11.1% during the forecast period from 2024 to 2033.
In recent years, facial injectables have seen a rise in demand due to consumers’ increasing focus on their physical appearance. Market growth is also driven by the increasing awareness of minimally invasive procedures, as well as various beauty campaigns organized by market leaders. Video calls have been increasing due to the ongoing COVID-19 epidemic. The ‘Zoom Boom’ is a term that describes an increase in awareness about one’s appearance. Botox is a popular cosmetic surgery that has seen an increase in demand.
Facial injectables are fillers designed specifically to target different facial regions for various uses such as dark circle reduction, brow lift enhancement, lip thinning or cheekbone enlargement – among others. Facial injectables can also help minimize wrinkles and restore skin affected by age, acne or scars. Common application points for facial injectables include Nasolabial folds, cheekbones lips corners of eye dorsal areas as well as dorsal hands.
Awareness of minimally invasive procedures due to various beauty campaigns conducted by leading industry participants is another force driving market expansion. Non-invasive aesthetic procedures and non-surgical market therapies such as facial injectable fillers and wrinkle relaxer injectables have seen threefold growth since 2012. Skin damage due to pollution or lifestyle choices drives up demand during this period, further fuelling demand during projection.
*Actual Numbers Might Vary In The Final Report
Key Takeaways
- Market Size & Growth: Facial Injectables Market size is expected to be worth around USD 40.4 Billion by 2033 from USD 14.1 Billion in 2023, growing at a CAGR of 11.1%
- Product Analysis: Botulinum Toxin Type A dominated the market, accounting for 48.2% of the total revenue in 2023
- Application Analysis:The market’s largest segment, facial line correction, accounted for 34.2 % of the total revenue in 2023
- Regional Analysis: North America was the dominant market, accounting for more than 40.5% of the total revenue in 2023 and holding a USD 5.7 billion value for the Facial Injectable Market
- Key trends: The demand for non-surgical cosmetic procedures is increasing, as they offer less downtime and fewer risks than traditional surgical procedures.
- Competitive landscape: The global facial injectable market is a fragmented market with a large number of players.
- Future outlook: The global facial injectable market is expected to continue to grow in the coming years, driven by the increasing demand for minimally invasive cosmetic procedures and the growing awareness of facial injectables.
Product Analysis
Botulinum Toxin Type A dominated the market, accounting for 48.2% of the total revenue in 2023. Women in their middle years are more likely to use fillers and injectables, including Botox, to reverse the effects of aging. The fastest CAGR for Hyaluronic Acid (HA), is 7.4 % over the forecast period. It is well-known for its ability to retain moisture in the skin.
Hyaluronic Acid (HA) is expected to experience rapid expansion over the forecast period. HA is well known for keeping moisture within skin cells, giving skin an appearance of younger-looking appearance and prolonging age-delaying benefits. Cosmetic-grade HA boasts low molecular weight so as to penetrate deeply into epidermis where cells store water while simultaneously releasing antioxidants that delay skin aging processes.
This makes the skin appear healthier. HA is known for its moisture-binding property, which helps to maintain and enhance the skin’s plumpness. Cosmetic-grade, HA is low in molecular weight. This allows for deep penetration into the epidermis. It also retains water and releases antioxidants to slow down the aging process.
Application Analysis
The market’s largest segment, facial line correction, accounted for 34.2 % of the total revenue in 2023. This is due to an increasing number of facial injectables used for aesthetic procedures like wrinkles on the skin, lip lines, and facial lines.
Due to growing awareness and interest regarding physical appearance as well as rising disposable income for middle-class populations in developing nations such as India, injectables for facial cosmetic purposes are expected to see an upsurge in demand over the coming years.
In the next few years, facial injectables will be in high demand due to the growing interest in facial line correction and the increase in disposable income in middle-class countries like India. Over the forecast period.
Market Segments
Product
- Collagen & PMMA Microspheres
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Poly-L-Lactic Acid (PLLA)
- Other Products
Application
- Facial Line Correction
- Lip Augmentation
- Face Lift
- Acne Scar Treatment
- Lipoatrophy Treatment
- Other Applications
End-use
- MedSpa
- Dermatology Clinics
- Hospitals
Driver
Invasive Procedures Growth
By increasing demand, there has been an upsurge in minimally invasive surgical procedures (MIPT). Facial injectable market growth has been propelled by consumer preference for minimally invasive cosmetic treatments with little downtime and lower risks, thus driving demand for facial injectables and contributing significantly to market expansion. Non-surgical options for facial rejuvenation continue to gain in popularity and contribute significantly to this increase.
Trend
Steadily Rising Use of Dermal Fillers
Dermal fillers have emerged as one of the key trends in facial injectables market in recent years, thanks to their increasing demand. Dermal fillers designed to address wrinkles and restore facial volume have seen tremendous popularity; their growing use demonstrates consumers’ preference for versatile yet efficient solutions; with dermal fillers becoming one of the key drivers behind market expansion.
Opportunity
Growing Aging Population
Facial injectable markets see great opportunity in an expanding global aging population, where individuals seek cosmetic solutions to counteract signs of aging and counteract its appearances. Aging demographics with desires for youthful appearances is driving facial injectable demand – creating lucrative business opportunities for industry participants.
Challenge
Strict Regulatory Approval Processes
Facial injectable markets face unique regulatory approval processes which may prove time consuming and costly, which hamper timely introduction of innovative new products to market. Market players attempting to bring cutting-edge facial injectables onto shelves must therefore engage in intensive strategic planning in order to comply with all relevant rules in order to overcome regulatory roadblocks successfully.
Regional Analysis
North America was the dominant market, accounting for more than 40.5 % of the total revenue in 2023 and holding a USD 5.7 billion value for the Facial Injectable Market. This is due to the high geriatric population of the U.S.A and Canada, which is expected to drive the demand for facial injections in the future. The American Society of Plastic Surgeons (ASPS) compared the rate of growth in cosmetic surgery products between 2004 and 2020. The use of Botox injections grew by 835%, according to the ASPS.
In the future, North America will be a major revenue source for facial injectables. The Asia Pacific market will see the highest CAGR over the forecast period. Countries such as South Korea, Australia, and India are supporting the region. The demand for facial injections will rise due to the growing focus on physical appearance in these countries. India is expected to grow at the fastest rate during the forecast period.
*Actual Numbers Might Vary In The Final Report
Key Regions and Countries
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- Rest of Europe
- APAC
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- MEA
- GCC
- South Africa
- Israel
- Rest of MEA
Key Players Analysis
Large market players invest significant funds in their research and development departments to broaden their product offerings to reach a broader market. Top market players also focus on the implementation of strategic initiatives such as market changes such as new products or contracts or mergers and acquisitions that increase investments or form strategic relationships with other businesses; furthermore, top players in Facial Injectable markets also offer their products at affordable costs.
Market leaders of Facial Injectable products are contemplating investing in regional manufacturing facilities in order to reduce operating expenses of their businesses, with Facial Injectable being one of the top contenders in this space.
Market Key Players
- Ipsen
- Merz Pharma
- Suneva Medical, Inc.
- Medytox Inc.
- Sinclair Pharma
- Bloomage BioTechnology Corporation Limited
- Anika Therapeutics Inc.
- Prollenium Medical Technologies
- Galderma
- Allergan, Inc.
Recent Developments
Biocompatible fillers
- These biocompatible fillers, made of materials commonly found within our bodies such as hyaluronic acid and collagen, have less chance of causing allergic reactions or side effects when placed inside of them.
- Long-Lasting Fillers Long-acting fillers may last two years or longer and could save patients both time and money as they will no longer require injections as frequently.
New Delivery Techniques
- Microneedles are small needles used to deliver fillers under the skin with less pain and greater precision than traditional injection techniques.
- Microcannulas are safe needles designed to minimize damage to blood vessels and nerves, making them the better option when treating specific facial areas, like under-eye areas.
New uses for injectables
- Hair Restoration Injectables have recently gained increased use as an effective treatment option to address hair loss in both men and women, including stimulating new hair growth or filling out thin spots in thinning spots.
- Technological Advancements Artificial Intelligence (AI) AI technology is being employed to develop injectable products and tailor treatment plans specifically to each patient.
Report Scope
Report Features Description Market Value (2023) USD 14.1 Billion Forecast Revenue (2033) USD 40.4 Billion CAGR (2024-2033) 11.1 % Base Year for Estimation 2023 Historic Period 2017-2022 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered Product(Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Other Products) Application(Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Other Applications) End-use(MedSpa, Dermatology Clinics, Hospitals) Regional Analysis North America-US, Canada, Mexico;Europe-Germany, UK, France, Italy, Russia, Spain, Rest of Europe;APAC-China, Japan, South Korea, India, Rest of Asia-Pacific;South America-Brazil, Argentina, Rest of South America;MEA-GCC, South Africa, Israel, Rest of MEA Competitive Landscape Ipsen, Merz Pharma, Suneva Medical, Inc., Medytox Inc., Sinclair Pharma, Bloomage BioTechnology Corporation Limited, Anika Therapeutics Inc., Prollenium Medical Technologies, Galderma, Allergan, Inc. Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) Frequently Asked Questions (FAQ)
What is the Facial Injectable Market?The facial injectable market encompasses cosmetic products and procedures that involve injecting substances into the skin to enhance facial aesthetics and combat signs of aging.
How big is the Facial Injectable Market?The global Facial Injectable Market size was estimated at USD 14.1 Billion in 2023 and is expected to reach USD 40.4 Billion in 2033.
What is the Facial Injectable Market growth?The global Facial Injectable Market is expected to grow at a compound annual growth rate of 11.1%. From 2024 To 2033
Who are the key companies/players in the Facial Injectable Market?Some of the key players in the Facial Injectable Markets are Ipsen, Merz Pharma, Suneva Medical, Inc., Medytox Inc., Sinclair Pharma, Bloomage BioTechnology Corporation Limited, Anika Therapeutics Inc., Prollenium Medical Technologies, Galderma, Allergan, Inc.
What Drives the Growth of Facial Injectables?The market is primarily driven by the increasing demand for minimally invasive cosmetic procedures, with consumers opting for non-surgical solutions for facial rejuvenation.
What Trend is Emerging in the Facial Injectable Market?Dermal fillers are experiencing a surge in popularity, addressing wrinkles and restoring facial volume. This trend reflects a preference for versatile and effective non-surgical options.
What Opportunity Does the Aging Population Present?The expanding global aging population presents a significant opportunity for the facial injectable market, as individuals seek aesthetic solutions to counteract the signs of aging.
What Challenges Does the Market Face?Stringent regulatory approval processes pose a challenge, impacting the timely introduction of new products. Market players need to navigate complex regulations to bring innovative facial injectables to market.
- Ipsen
- Merz Pharma
- Suneva Medical, Inc.
- Medytox Inc.
- Sinclair Pharma
- Bloomage BioTechnology Corporation Limited
- Anika Therapeutics Inc.
- Prollenium Medical Technologies
- Galderma
- Allergan, Inc.
- settingsSettings
Our Clients
Single User $4,599 $3,499 USD / per unit save 24% | Multi User $5,999 $4,299 USD / per unit save 28% | Corporate User $7,299 $4,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,499) | Buy Now ($ 4,299) | Buy Now ($ 4,999) |